MAGGIE'S PEARL, LLC
Biotech · Private
Small-molecule therapeutic compounds (aldose reductase inhibitors) that increase mutant PMM2 enzyme activity to treat phosphomannose mutatase-2 congenital disorder of glycosylation (PMM2-CDG)
- Grants
- $1.8M
- 3 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 2
- 0 granted · 2 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓2021202220232024
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase II · Targeting aldose reductase: A Phase IIb/III trial for the novel use of Epalrestat to treat Congenital Disorders of Glycosylation (PMM2-CDG) | $699,884 | |
| Federal grant | Department of Health and Human Services · Phase II · Targeting aldose reductase: A Phase IIb/III trial for the novel use of Epalrestat to treat Congenital Disorders of Glycosylation (PMM2-CDG) | $553,056 | |
| Federal grant | Department of Health and Human Services · Phase II · Targeting aldose reductase: A Phase IIb/III trial for the novel use of Epalrestat to treat Congenital Disorders of Glycosylation (PMM2-CDG) | $553,056 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 3073 | Roivant Sciences | — | — |
| 3074 | ADVANCED GENETIC SYSTEMS, INC. | — | — |
| 3075 | IQ PROTEOMICS, LLC | — | — |
| 3076 | MAGGIE'S PEARL, LLC | — | — |
| 3077 | CELETRIX, LLC | — | — |
| 3078 | Myeloid Therapeutics | — | — |
| 3079 | Cardior Pharmaceuticals | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Methods For Treating Congenital Disorders Of Glycosylationapplication
- Methods For Treating Congenital Disorders Of Glycosylationapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.